ASTRAZENECA PLC DL-,25/ GB0009895292 /
2024-04-26 7:32:06 PM | Chg. +0.55 | Volume | Bid7:32:09 PM | Ask7:32:09 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
139.75EUR | +0.40% | 0 Turnover: 0.00 |
139.70Bid Size: 60 | 140.85Ask Size: 60 | 216.53 bill.EUR | - | - |
GlobeNewswire
03-28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...
GlobeNewswire
02-02
BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patie...